Translating Novel & Transformational Analgesics into the Clinic

Transforming Efficacy & Tolerability of Pain Management with Nav 1.8 & Other Targets for Neuropathic, Chemotherapy-Induced, Musculoskeletal & Other Types of Pain

For more than two decades, biopharma has struggled to develop safe and effective non-opioid pain therapies. With Vertex’s recent approval marking a long-awaited breakthrough, the momentum has reached a critical point for bringing non-opioid pain therapeutics to market.

Whether advancing NaV-targeting drugs or pursuing novel pain mechanisms, non-opioid therapeutics are now in the clinical spotlight and the next 12 months promise to be transformative.

This summit provides a dedicated platform to harness that momentum. Attendees will be learning from companies with approvals such as Tonix and Vertex, exploring late-stage strategies from innovators like Latigo and Algiax, and uncovering discovery breakthroughs from Nocion and Axonis. Join 70+ discovery, preclinical, translational and clinical industry-based experts driving the future of non-opioid pain therapies across diverse pain indications.

Those are the hugest unmet needs, of people who go to their doctor and want something to improve their quality of life because of the pain they're experiencing.

Merck

Merck - Non-Opioid Pain Therapeutics Summit

I do see this trend now towards, you know, everyone getting back in to the pain space.

Eli Lilly

Eli Lilly - Non-Opioid Pain Therapeutics Summit

It's great to have the opportunity to have conferences like this to get industry together. You know, there's a lot of overlap in many of the programs across industry and having the forum to offer different ways of approaching the same question, is always a welcome opportunity definitely.

Eli Lilly

Eli Lilly - Non-Opioid Pain Therapeutics Summit

Explore the Full Event Guide

  • 16+ world class speakers
  • 3 days of packed content from industry experts
  • 2 interactive workshops with practical insights
  • Your dedicated forum to the pharmaceutical development of non-opioid pain therapeutics
Placeholder Image

More than a Meeting

70+

Industry Dedicated Attendees

16

World-Class Speakers

5+

Hours of Dedicated Networking

3

Days of Packed Content From Industry Experts

2

Interactive Workshops With Practical Insights

Attending Companies Include

Vertex logo - Non-Opioid Pain Therapeutics Summit
Eli Lilly logo - Non-Opioid Pain Therapeutics Summit
merck logo - Non-Opioid Pain Therapeutics Summit
novartis logo - Non-Opioid Pain Therapeutics Summit
AbbVie_logo - Non-Opioid Pain Therapeutics Summit
Latigo - Non-Opioid Pain Therapeutics Summit
Averitas - Non-Opioid Pain Therapeutics Summit
Quiver Bioscience - Non-Opioid Pain Therapeutics Summit
orion - Non-Opioid Pain Therapeutics Summit
onsite image 2
Explore the Agenda

Interactive workshops, pharma panels and case-study led presentations: hear the industries exclusive insights

onsite image 3
Partner With Us

Position yourself alongside pioneering biopharma to centre your solutions at the heart of a booming industry

onsite image 4
Join Pain Experts

Be part of critical conversations with expert- attendees during dedicated networking hours